A Phase I Study of Ganetespib +/- bortezomib and dexamethasone in patients with relapsed/refractory multiple myeloma
Phase of Trial: Phase I
Latest Information Update: 14 Oct 2015
At a glance
- Drugs Ganetespib (Primary) ; Bortezomib; Dexamethasone
- Indications Multiple myeloma
- Focus Adverse reactions
- 09 Oct 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 26 Mar 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 14 Mar 2014 Planned end date changed from 1 Apr 2014 to 1 Sep 2015 as reported by ClinicalTrials.gov.